← Back

Shinva Medical Instrument Co Ltd

Shinva Medical Instrument Co., Ltd. provides medical devices, pharmaceutical equipment, medical services, and medical trade in the People's Republic of China. It operates in four segments: Medical Device Products, Medical Trade Products, Pharmaceutical Equipment Products, and Medical Services. The company offers infection control instruments, radiotherapy equipment, surgical instruments, biomedical consumables, operating room solutions, dental units, laboratory equipment, hemodialyzers, orthopedic implants, in vitro diagnostics, and pharmaceutical equipment such as injection solutions and aseptic systems. Founded in 1943, it is headquartered in Zibo, China.

Country
Price · split & dividend adjusted
News & notes moving 600587.CG
600587.CG

Shinva Medical Instrument Receives Registration Certificates for Two Medical Devices

Shinva Medical Instrument announced that its respiratory gating system has received a Class III medical device registration certificate from the National Medical Products Administration. The system is used to collect patient respiratory pattern information to coordinate with CT equipment for acquiring synchronized images and monitoring position. Its thoracoscopic surgical instruments have received a Class II medical device registration certificate from the Shandong Provincial Medical Products Administration. The instruments consist of vascular forceps, tissue forceps, needle holders, thoracic scissors, and other components, and are used in conjunction with thoracoscopes. The company stated that the two products will respectively create synergy with its existing large-bore CT positioning equipment and endoscopic camera systems, strengthening its competitiveness in precision radiotherapy and minimally invasive endoscopic surgery.
Jiemian·17dRead more →
600587.CG

Shinva Medical's 2026 interim net profit was 285 million yuan, down 26.04% year-on-year

Shinva Medical Instrument released its 2026 interim report. Total operating revenue was 5.161 billion yuan, up 7.73% year-on-year, but net profit attributable to the parent company was 285 million yuan, down 26.04% year-on-year. Net cash inflow from operating activities was 265 million yuan, down 26.04% year-on-year. The company's asset-liability ratio was 45.21%, gross margin was 24.93%, return on equity was 3.63%, and diluted earnings per share was 0.47 yuan, down 26.56% year-on-year. Total asset turnover was 0.35 times, up 11.76% year-on-year, and inventory turnover was 1.40 times, up 25.77% year-on-year, achieving growth for two consecutive years. The company had 42,800 shareholders, and the top ten shareholders held 40.04% of total share capital.
Jiemian·21dRead more →
600587.CG

Xinhua Medical Subsidiary Obtains Class III Registration Certificate for Disposable Plasma Surgical Electrode

Xinhua Surgical Instruments, a subsidiary of Xinhua Medical, recently obtained a Class III medical device registration certificate issued by the National Medical Products Administration for its disposable plasma surgical electrode. The certificate was approved on August 17, 2026, and is valid until August 16, 2031. The product is used with plasma surgical equipment in a saline environment for cutting and coagulating soft tissue in the ear, nose, and throat during open or endoscopic surgery, offering advantages such as low-temperature cutting, minimal thermal damage, and precise bipolar structure.
Jiemian·30dRead more →
Biotech & Genomic Medicine

Xinhua Medical to invest 80 million yuan in wholly owned subsidiary Xinhua Endoscopy

Xinhua Medical announced that its board of directors has approved a proposal for its wholly owned subsidiary Huatuo International to invest 80 million yuan to establish Xinhua Platinum Vision Endoscopy Shanghai Co., Ltd., with a registered capital of 80 million yuan. The main business will be the production and distribution of Class II and Class III medical devices. Xinhua Medical stated that Xinhua Endoscopy will focus on specialized fields such as gastroenterology, respiratory, and urology, and through the research and innovation of high-end medical devices like flexible endoscopes, it will drive the company's product upgrade from basic support to precision diagnosis and treatment.
Jiemian·39dRead more →
600587.CG

Xinhua Medical's Fully Automatic Blood Typing Analyzer and Vertical Steam Sterilizer Receive Registration Certificates

Xinhua Medical announced that the company recently received a Class III medical device registration certificate from the National Medical Products Administration for its fully automatic blood typing analyzer, and a Class II medical device registration certificate from the Shandong Medical Products Administration for its vertical steam sterilizer. The fully automatic blood typing analyzer uses the column agglutination method for ABO blood grouping, RhD blood grouping, irregular antibody screening, and cross-matching tests. The vertical steam sterilizer employs gravity displacement and positive pressure pulsation cold air removal methods for sterilizing moisture- and heat-resistant medical devices.
Jiemian·45dRead more →
600587.CG

Shinva Medical Instrument Obtains Class III and Class II Medical Device Registration Certificates for Multiple Products

Shinva Medical Instrument announced that the company and its subsidiary Shinva Surgical Instruments have recently obtained multiple medical device registration certificates issued by the Shandong Medical Products Administration and the National Medical Products Administration. Among them, the disposable plasma surgical electrode received a Class III registration certificate, to be used with plasma surgical equipment for joint soft tissue cutting and coagulation. The hysteroscope, large benchtop steam sterilizer, flexible endoscope washer-disinfector, and multi-functional cleaning and disinfection center received Class II registration certificates, respectively used for gynecological uterine cavity examination and minimally invasive treatment, sterilization of moisture- and heat-resistant medical devices, second-generation isolated washing and disinfection, and integration of six functional units. The company stated that the approval of the above products will improve the product matrix in the fields of minimally invasive surgery and infection control, enhancing comprehensive competitiveness, but actual sales depend on market promotion effectiveness, and the specific impact on performance cannot be predicted at this time.
Jiemian·53dRead more →
600587.CG

Xinhua Medical's Mobile C-Arm X-Ray Machine and Urethrocystoscope Receive Class II Medical Device Registration Certificates

Xinhua Medical announced that the company and its subsidiary Xinhua Surgical Instruments have recently obtained the Medical Device Registration Certificate of the People's Republic of China issued by the Shandong Medical Products Administration. The company's self-developed mobile C-arm X-ray machine, including four models such as the MDC660i, is suitable for surgical fluoroscopy and radiography, while the subsidiary Xinhua Surgical Instruments' urethrocystoscope is suitable for examination and surgery of diseases in the urethra or bladder.
Jiemian·67dRead more →
600587.CG

Yonghe Intelligent Control sells its last hospital starting at 1 yuan, as cross-sector healthcare push rapidly recedes

Yonghe Intelligent Control is transferring its 70 percent stake in Liangshan High-Tech Oncology Hospital at a listing price of 1 yuan, drawing a line under its cross-sector healthcare strategy. The hospital was an asset the company acquired in December 2021 for 31.5 million yuan, and just one month ago the listing price was still 1.87 million yuan. Previously, the company's hospital stakes in Dazhou and Xi'an were both sold at a floor price of 1 yuan, with final transaction prices of just 101 yuan and 201 yuan respectively, while the Kunming hospital was sold for 16.683 million yuan, equivalent to a 15 percent discount on its 108 million yuan acquisition price. Yonghe Intelligent Control has posted losses for four consecutive years from 2022 to 2025, with cumulative losses of about 619 million yuan, and its hospitals have racked up combined losses of nearly 80 million yuan. The cross-sector hospital investment fever among listed companies is rapidly cooling. Shinva Medical has offloaded 11 hospitals in five years, DADONG FANG transferred its 80 percent stake in Jinhua Lianji Hospital for 1 yuan, and companies such as China Resources Sanjiu and Yibai Pharmaceutical have also been divesting hospital assets.
读创财经·72dRead more →